⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
ZFP423 Antisense Oligonucleotide (Adipose Thermogenesis)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-25 — An RNA thermogenic therapy to preserve lean mass and enhance metabolic health during GLP-1 weight loss.: Mouse study: weekly adipose-directed ASOs against ZFP423 induced white-adipose beiging, raised thermogenesis and oxygen consumption, and — combined with semaglutide — amplified fat loss while preserving lean mass and improving metabolic markers in lean and DIO mice. [animal-model] (novelty: 4)
Open questions
Related
Contributing findings
An RNA thermogenic therapy to preserve lean mass and enhance metabolic health during GLP-1 weight loss.
25-sep-2026
novelty 4
per-area 4
strengthens